Humira Travel Letter
Humira Travel Letter
Date: October 8, 2050
To Whom It May Concern,
I am writing to confirm that Jewell Ward is under my care for the treatment of a chronic autoimmune condition that necessitates the use of Humira (adalimumab). This medication is essential for managing her symptoms and ensuring her quality of life.
As her treating physician, I can attest to the importance of maintaining a consistent treatment regimen, which includes the administration of Humira. During her upcoming travels, it is crucial that she continues her treatment without interruption.
Jewell will be traveling to New York City from October 15, 2050, to October 22, 2050, and will be carrying her Humira medication with her. It is important to note that Humira must be stored at a controlled temperature of 2°C to 8°C (36°F to 46°F) and should not be exposed to direct sunlight or extreme heat.
I kindly request that you accommodate her medical needs during her travel, and allow her to bring her medication aboard and store it appropriately to ensure its efficacy.
If you have any questions or require further information regarding Jewell's treatment, please feel free to contact me directly. Thank you for your understanding and cooperation in this matter.
Sincerely,
[Your Name]
Attending Physician
[Your Email]
[Your Company Name]
